Ombitasvir/paritaprevir/ritonavir + dasabuvir +/- ribavirin in real world hepatitis C patients.

CONCLUSION: In an all-comers HCV GT1 population, 12 or 24-wk of OBV/PTV/r + DSV +/- RBV is highly effective and tolerable and results in better mental and physical health following treatment.
PMID: 31143073 [PubMed - in process]

Source: World Journal of Gastroenterology : WJG - May 13, 2019 Category: Gastroenterology Authors: Loo N, Lawitz E, Alkhouri N, Wells J, Landaverde C, Coste A, Salcido R, Scott M, Poordad F Tags: World J Gastroenterol Source Type: research